Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 111


Multiple RT-PCR markers for the detection of circulating tumour cells of metastatic canine mammary tumours.

da Costa A, Kohn B, Gruber AD, Klopfleisch R.

Vet J. 2013 Apr;196(1):34-9. doi: 10.1016/j.tvjl.2012.08.021. Epub 2012 Oct 1.


Potential markers for detection of circulating canine mammary tumor cells in the peripheral blood.

da Costa A, Oliveira JT, Gärtner F, Kohn B, Gruber AD, Klopfleisch R.

Vet J. 2011 Oct;190(1):165-8. doi: 10.1016/j.tvjl.2010.09.027. Epub 2010 Nov 3.


Identification of six potential markers for the detection of circulating canine mammary tumour cells in the peripheral blood identified by microarray analysis.

da Costa A, Lenze D, Hummel M, Kohn B, Gruber AD, Klopfleisch R.

J Comp Pathol. 2012 Feb-Apr;146(2-3):143-51. doi: 10.1016/j.jcpa.2011.06.004. Epub 2011 Jul 23.


Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.

Fabisiewicz A, Kulik J, Kober P, Brewczyńska E, Pieńkowski T, Siedlecki JA.

Acta Biochim Pol. 2004;51(3):747-55.


Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.

Obermayr E, Sanchez-Cabo F, Tea MK, Singer CF, Krainer M, Fischer MB, Sehouli J, Reinthaller A, Horvat R, Heinze G, Tong D, Zeillinger R.

BMC Cancer. 2010 Dec 3;10:666. doi: 10.1186/1471-2407-10-666.


Possible role of Snail expression as a prognostic factor in canine mammary neoplasia.

Im KS, Kim JH, Kim NH, Yu CH, Hur TY, Sur JH.

J Comp Pathol. 2012 Aug-Oct;147(2-3):121-8. doi: 10.1016/j.jcpa.2011.12.002. Epub 2012 Jan 31.


Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.

Stathopoulou A, Mavroudis D, Perraki M, Apostolaki S, Vlachonikolis I, Lianidou E, Georgoulias V.

Anticancer Res. 2003 Mar-Apr;23(2C):1883-90.


Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.

Zhao S, Yang H, Zhang M, Zhang D, Liu Y, Liu Y, Song Y, Zhang X, Li H, Ma W, Zhang Q.

Cell Biochem Biophys. 2013 Mar;65(2):263-73. doi: 10.1007/s12013-012-9426-2.


Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.

Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE, Hoon DS.

Cancer Res. 2001 Dec 15;61(24):8845-50.


Molecular detection of peripheral blood breast cancer mRNA transcripts as a surrogate biomarker for circulating tumor cells.

Lasa A, Garcia A, Alonso C, Millet P, Cornet M, Ramón y Cajal T, Baiget M, Barnadas A.

PLoS One. 2013 Sep 18;8(9):e74079. doi: 10.1371/journal.pone.0074079. eCollection 2013.


mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.

Marchetti A, Buttitta F, Bertacca G, Zavaglia K, Bevilacqua G, Angelucci D, Viacava P, Naccarato A, Bonadio A, Barassi F, Felicioni L, Salvatore S, Mucilli F.

J Pathol. 2001 Sep;195(2):186-90.


Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.

Gorges TM, Tinhofer I, Drosch M, Röse L, Zollner TM, Krahn T, von Ahsen O.

BMC Cancer. 2012 May 16;12:178. doi: 10.1186/1471-2407-12-178.


Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.

Cancer Res. 2001 Mar 15;61(6):2523-32.


Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer—evaluation of several markers with real-time reverse transcription-PCR.

Andergassen U, Hofmann S, Kölbl AC, Schindlbeck C, Neugebauer J, Hutter S, Engelstädter V, Ilmer M, Friese K, Jeschke U.

Int J Mol Sci. 2013 Jan 8;14(1):1093-104. doi: 10.3390/ijms14011093.


Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.

Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, Hoon DS.

J Clin Oncol. 1998 Aug;16(8):2632-40.


Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay.

Markou A, Strati A, Malamos N, Georgoulias V, Lianidou ES.

Clin Chem. 2011 Mar;57(3):421-30. doi: 10.1373/clinchem.2010.154328. Epub 2011 Jan 18.


Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.

Klopfleisch R, Gruber AD.

J Comp Pathol. 2009 Aug-Oct;141(2-3):113-20. doi: 10.1016/j.jcpa.2008.09.010. Epub 2009 Jun 9.


Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.

Schröder CP, Ruiters MH, de Jong S, Tiebosch AT, Wesseling J, Veenstra R, de Vries J, Hoekstra HJ, de Leij LF, de Vries EG.

Int J Cancer. 2003 Sep 10;106(4):611-8.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk